Table 2 Outcome of ovarian stimulation
Cabergoline group (n = 118) | Antagonist rescue combined with cabergoline group (n = 118) | P value | |
|---|---|---|---|
Duration of HP-uFSH Stimulation (days) | 9.92 ± 0.85 | 10.08 ± 0.68 | 0.129 |
Total HP-uFSH ampoules (75U) | 29.88 ± 6.8 | 27.87 ± 5.58 | 0.014 |
Estradiol level on the HCG day (pg/ml) | 5501 ± 1122 | 2811 ± 399 | <0.001 |
No. of retrieved oocytes | 19.09 ± 4.01 | 18.85 ± 4.37 | 0.651 |
No. of metaphase II oocytes | 17.02 ± 3.8 | 16.97 ± 3.94 | 0.933 |
No. of fertilized oocytes | 13.69 ± 3.32 | 13.42 ± 3.08 | 0.523 |
Fertilization rate | 1584/2003(79.08 %) | 1561/1940(80.46 %) | 0.28 |
No. of high quality embryos | 4.02 ± 1.28 | 3.84 ± 1.31 | 0.295 |
No. of embryos transferred | 2.32 ± 0.47 | 2.26 ± 0.44 | 0.303 |
Cycles cancelled | 4/118(3.39 %) | 0/118(0 %) | 0.122 |
Moderate or severe OHSS | 16/118(13.56 %) | 6/118(5.08 %) | 0.025 |
Moderate OHSS | 12/118(10.17 %) | 6/118(5.08 %) | 0.141 |
Severe OHSS | 4/118(3.39 %) | 0/118(0 %) | 0.122 |
Early onset OHSS | 12/118(10.17 %) | 5/118(4.24 %) | 0.078 |
Late onset OHSS | 4/118(3.39 %) | 1/118(0.85 %) | 0.37 |